Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation.
In this study, we have assessed four strains of Prevotella intermedia, isolated from periodontally involved lesions, for their ability to inhibit lymphocyte functions. All four strains were found to cause a dose-dependent inhibition of B- and T-cell proliferation in response to mitogens and antigens. This was reflected in altered DNA, RNA, and protein syntheses. Furthermore, P. intermedia appeared to affect the early stages of cell activation. This was ascertained by kinetic analysis in which it was determined that the extract had to be present during the first 24 h of incubation to cause suppression. Moreover, direct assessment of the early stages of cell activation indicated that release of cytokines and expression of the interleukin 2 receptor and CD69 on T cells were inhibited by P. intermedia sonic extracts. Finally, preliminary characterization of the immunosuppressive agent indicates that it has a molecular mass of approximately 50 kDa and is heat labile. It has been proposed that impaired host defense may play a pivotal role in the pathogenesis of many infections. The data presented in this paper suggest that microbially mediated immunosuppression may contribute to the pathogenesis of periodontal disease by altering the nature and consequences of host-parasite interactions.
Department of Pathology, University of Pennsylvania, School of Dental Medicine, Philadelphia 19104-6002.
B J
BJ
Shenker
L
L
Vitale
J
J
Slots
D001439:Bacteroides / Q000472:pathogenicity*; D006801:Humans; D007108:Immune Tolerance; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000502:physiology; D008213:Lymphocyte Activation; D010510:Periodontal Diseases / Q000209:etiology; D015375:Receptors, Interleukin-2 / Q000032:analysis
D007376:Interleukin-2; D015375:Receptors, Interleukin-2